Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in ...

This week on "The Readout LOUD" podcast: new hope in treating Huntington's disease and a report card on RFK Jr.'s promises.

Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a ...

Here in the U.S., infant formula has a good overall safety record. But the stakes are incredibly high if something goes wrong ...

Washington’s vaccine wars are escalating again as Senate Democrats seek to build a paper trail around Health Secretary Robert ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

A new poll shows only about half of U.S. adults could afford their health care and had access to quality care last year.

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do, STAT's Adam ...

GLP-1 weight loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound have been on the market for a few years now. The ...

For this story, Boodman obtained email chains between Pfizer and health officials and conducted interviews with 10 state health departments, eight local health agencies, six health system pharmacists, ...

A new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.